Vimarsana
Biggest News Aggregation in the World

Page 10 - Nasdaq Pcvx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Pcvx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Pcvx Today - Breaking & Trending Today

Vaxcyte, Inc. (NASDAQ:PCVX) Given Average Rating of "Buy" by Analysts - Vimarsana News

Vaxcyte, Inc. (NASDAQ:PCVX) Given Average Rating of "Buy" by Analysts

Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) have been given an average recommendation of “Buy” by the eight ratings firms that are covering the stock, Marketbeat reports. Five research analysts have rated the stock with a buy rating. The average 12-month price target among brokerages that have issued ratings on the stock in the […]

888 Reaffirms "Reiterates" Rating for Vaxcyte (NASDAQ:PCVX) - Vimarsana News

888 Reaffirms "Reiterates" Rating for Vaxcyte (NASDAQ:PCVX)

888 reiterated their reiterates rating on shares of Vaxcyte (NASDAQ:PCVX – Get Rating) in a report published on Tuesday morning, Benzinga reports. Other equities research analysts also recently issued reports about the stock. Needham & Company LLC reissued a buy rating and set a $58.00 price target on shares of Vaxcyte in a research note […]

FY2023 EPS Estimates for Vaxcyte, Inc. (NASDAQ:PCVX) Lifted by Cantor Fitzgerald - Vimarsana News

FY2023 EPS Estimates for Vaxcyte, Inc. (NASDAQ:PCVX) Lifted by Cantor Fitzgerald

Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) – Equities researchers at Cantor Fitzgerald boosted their FY2023 EPS estimates for shares of Vaxcyte in a report issued on Tuesday, May 9th. Cantor Fitzgerald analyst L. Chen now expects that the company will earn ($3.15) per share for the year, up from their prior estimate of ($3.93). The […]

Vaxcyte (NASDAQ:PCVX) Given Reiterates Rating at 888 - Vimarsana News

Vaxcyte (NASDAQ:PCVX) Given Reiterates Rating at 888

Vaxcyte (NASDAQ:PCVX – Get Rating)‘s stock had its “reiterates” rating restated by analysts at 888 in a report issued on Tuesday, Benzinga reports. A number of other equities research analysts have also issued reports on PCVX. Bank of America upped their target price on Vaxcyte from $63.00 to $68.00 in a research note on Monday, […]

Source: wkrb13.com
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Recommendation of "Buy" from Brokerages - Vimarsana News

Vaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Recommendation of "Buy" from Brokerages

Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) has been assigned an average recommendation of “Buy” from the eight brokerages that are currently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have issued a report on the stock in the last […]